Licensing and collaboration agreements, integral to the life sciences and tech industries, are increasingly complex from an antitrust perspective.

First in a two-part series covering the regulatory landscape in innovation-driven industries, in this episode of the Essential Antitrust podcast our host Meghan Rissmiller is joined by Tone Oeyen, partner in Brussels, Jenny Leahy, senior associate in London and Kristen Riemenschneider, partner in Washington DC to discuss the cross-border regulatory considerations that arise throughout the lifespan of licensing and collaboration agreements.